Cargando…

Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery

Symptomatic isolated dissection of the superior mesenteric artery (SIDSMA) represents an extremely rare condition. Although various treatments including conservative treatment, endovascular stenting (ES), and surgical repair are currently available, consensus treatment guideline is absent due to sca...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zilun, Ding, Huanyu, Shan, Zhen, Du, Jianliang, Yao, Chen, Chang, Guangqi, Wang, Shenming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912307/
https://www.ncbi.nlm.nih.gov/pubmed/26559313
http://dx.doi.org/10.1097/MD.0000000000002058
_version_ 1782438248760475648
author Li, Zilun
Ding, Huanyu
Shan, Zhen
Du, Jianliang
Yao, Chen
Chang, Guangqi
Wang, Shenming
author_facet Li, Zilun
Ding, Huanyu
Shan, Zhen
Du, Jianliang
Yao, Chen
Chang, Guangqi
Wang, Shenming
author_sort Li, Zilun
collection PubMed
description Symptomatic isolated dissection of the superior mesenteric artery (SIDSMA) represents an extremely rare condition. Although various treatments including conservative treatment, endovascular stenting (ES), and surgical repair are currently available, consensus treatment guideline is absent due to scarce of SIDSMA cases. Thus, we present our experience in the treatment of SIDSMA at our single center. Fourteen cases of SIDSMA were treated with conservative treatment, catheter-directed thrombolysis (CDT), endovascular stenting (ES), or surgical repair at our center between January 2008 and January 2014. Demographics, clinical manifestations, coexisting medical conditions, imaging feature, treatments, and follow-up outcome of these patients were retrospectively collected and analyzed. For 13 patients without peritonitis, conservative treatment was given for 4 to 6 days initially. After the first observation cycle, symptoms and signs were alleviated in 8 patients, and conservative treatments were continued. The remaining 5 patients received technically and clinically successful ES (in 4) or CDT (in 1) due to worsening symptoms and signs during conservative treatment. One patient with peritonitis underwent emergency surgery, with the necrotic small intestine resected. However, the abdominal pain was not alleviated 17 days postoperatively, ES was thus performed and symptoms relieved immediately. Two weeks after ES, a new aneurysm and partial thrombosis in the distal part of the stent were found by computed tomography angiography in this patient. No intestinal infarction or mortality developed during hospitalization. Follow-up was accomplished in 11 cases, ranging from 4 to 74 months (23.5 ± 21.3). Except that one complained with mild abdominal pain, the other 10 achieved complete remission. All patients were free from new aneurysmal formation of SMA and all stents remained patent. For SIDSMA without peritonitis, conservative treatment can be provided with reasonable success rate, while ES may serve as an effective alternative once conservative treatment fails. For SIDSMA with peritonitis, open surgery remains the treatment of choice by resection of necrotic intestine and revasculization.
format Online
Article
Text
id pubmed-4912307
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-49123072016-06-28 Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery Li, Zilun Ding, Huanyu Shan, Zhen Du, Jianliang Yao, Chen Chang, Guangqi Wang, Shenming Medicine (Baltimore) 3400 Symptomatic isolated dissection of the superior mesenteric artery (SIDSMA) represents an extremely rare condition. Although various treatments including conservative treatment, endovascular stenting (ES), and surgical repair are currently available, consensus treatment guideline is absent due to scarce of SIDSMA cases. Thus, we present our experience in the treatment of SIDSMA at our single center. Fourteen cases of SIDSMA were treated with conservative treatment, catheter-directed thrombolysis (CDT), endovascular stenting (ES), or surgical repair at our center between January 2008 and January 2014. Demographics, clinical manifestations, coexisting medical conditions, imaging feature, treatments, and follow-up outcome of these patients were retrospectively collected and analyzed. For 13 patients without peritonitis, conservative treatment was given for 4 to 6 days initially. After the first observation cycle, symptoms and signs were alleviated in 8 patients, and conservative treatments were continued. The remaining 5 patients received technically and clinically successful ES (in 4) or CDT (in 1) due to worsening symptoms and signs during conservative treatment. One patient with peritonitis underwent emergency surgery, with the necrotic small intestine resected. However, the abdominal pain was not alleviated 17 days postoperatively, ES was thus performed and symptoms relieved immediately. Two weeks after ES, a new aneurysm and partial thrombosis in the distal part of the stent were found by computed tomography angiography in this patient. No intestinal infarction or mortality developed during hospitalization. Follow-up was accomplished in 11 cases, ranging from 4 to 74 months (23.5 ± 21.3). Except that one complained with mild abdominal pain, the other 10 achieved complete remission. All patients were free from new aneurysmal formation of SMA and all stents remained patent. For SIDSMA without peritonitis, conservative treatment can be provided with reasonable success rate, while ES may serve as an effective alternative once conservative treatment fails. For SIDSMA with peritonitis, open surgery remains the treatment of choice by resection of necrotic intestine and revasculization. Wolters Kluwer Health 2015-11-13 /pmc/articles/PMC4912307/ /pubmed/26559313 http://dx.doi.org/10.1097/MD.0000000000002058 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3400
Li, Zilun
Ding, Huanyu
Shan, Zhen
Du, Jianliang
Yao, Chen
Chang, Guangqi
Wang, Shenming
Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title_full Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title_fullStr Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title_full_unstemmed Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title_short Initial and Middle-Term Outcome of Treatment for Spontaneous Isolated Dissection of Superior Mesenteric Artery
title_sort initial and middle-term outcome of treatment for spontaneous isolated dissection of superior mesenteric artery
topic 3400
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912307/
https://www.ncbi.nlm.nih.gov/pubmed/26559313
http://dx.doi.org/10.1097/MD.0000000000002058
work_keys_str_mv AT lizilun initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT dinghuanyu initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT shanzhen initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT dujianliang initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT yaochen initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT changguangqi initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery
AT wangshenming initialandmiddletermoutcomeoftreatmentforspontaneousisolateddissectionofsuperiormesentericartery